Federal Perspectives on the Future of Addiction Care and Opportunities for Science to Advance Service Delivery

October 16, 2024, 1:30-3 PM

Senior leaders from three federal agencies will discuss current and anticipated challenges and relevant opportunities for science to inform and improve addiction care service delivery. The Substance Abuse and Mental Health Services Administration provides funding for the continuum of services related to addiction care across the United States. The National Institute on Alcohol Abuse and Alcoholism and the National Institute on Drug Abuse are major research funders for addiction health services research.


Tisha Wiley

Chief, Services Research Branch and Associate Director, Criminal Justice, National Institute on Drug Abuse, National Institutes of Health

Yngvild Olsen

Director, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration

Laura Kwako

Chief, Treatment, Health Services, & Recovery Branch, Division of Treatment and Recovery at the National Institute on Alcohol Abuse and Alcoholism

Emerging Substances in the Illicit Drug Supply: Assessing the Fentanyl-Xylazine Threat

October 17, 2024, 8-9 AM

Adulterants in illicit drugs are ubiquitous and of variable significance. Xylazine, a veterinary sedative, has been increasingly detected in illicit opioids and has been associated with substantial medical complications. The pharmacology, epidemiology, and pathophysiology of fentanyl-xylazine admixtures will be described. Exposure prevention and overdose mitigation utilizing harm reduction, drug checking and biosurveillance data will be highlighted to inform the public health response.


Jeanmarie Perrone

Professor, Emergency Medicine, Medical Toxicology and Addiction Medicine and Director, Center for Addiction Medicine and Policy, University of Pennsylvania

The Streets of San Francisco: Front Line Response to the Opioid Epidemic

October 17, 2024, 1:45-2:45 PM

San Francisco, a legendary city known for inclusivity and innovation, provides a unique context within which to examine addiction prevention, treatment and recovery services, and stimulate discussion about clinical, health services, and implementation research needs. Moderated by Mark McGovern, this plenary session is a fireside chat with three individuals addressing the opioid epidemic in critically important roles on a daily basis: Dr. Phillip Coffin, Mr. Dominique McDowell, and Ms. Josette Rojo.


Phillip O. Coffin

Director, Center on Substance Use and Health, San Francisco Department of Public Health

Dominique McDowell

Director, Addiction Services, Marin County Health and Wellness Center

Josette Rojo

Patient Navigator, Office-Based Induction Clinic, Home Outreach Prevention Engagement Team, University of California, San Francisco

Addiction Science Enters the Public Policy Arena

October 18, 2024, 8-9 AM

Although implementation science prioritizes translating research insights into clinical practice, it can also bring evidence into the formation of policies regarding alcohol, tobacco, illicit drugs, and addiction. This presentation reviews examples of efforts to bring addiction-focused science to public policy, and draws general conclusions about the motives, strategies, and mindset that facilitate success. The presentation concludes with a summary of key areas where the contribution of science to public policy is particularly needed right now.


Keith Humphreys

Esther Ting Memorial Professor, Stanford University School of Medicine